JadeBio
Private Company
Funding information not available
Overview
Founded in 2008 and headquartered in San Diego, JadeBio operates as a specialized contract research organization (CRO) providing high-end proteomics services. Its core expertise lies in mass spectrometry, offering services from targeted protein quantitation to full proteome profiling and complex protein characterization, including complete antibody sequencing. The company leverages AI/ML, as indicated by its sector focus, to enhance data analysis, positioning itself at the intersection of advanced genomics, proteomics, and computational biology for academic, biotech, and pharma clients.
Technology Platform
Proprietary mass spectrometry-based proteomics platform for sample preparation, deep proteome coverage, quantitative analysis (relative/absolute), post-translational modification detection, and antibody characterization. Integrates AI/ML for data analysis.
Opportunities
Risk Factors
Competitive Landscape
JadeBio competes with large CROs (e.g., Charles River, LabCorp) with broad service portfolios, specialized proteomics firms (e.g., Biognosys, Olink for certain niches), and university core facilities. Its differentiation lies in proprietary preparation for diverse sample types and deep expertise in complex protein characterization like full antibody sequencing.